Division of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Respirology. 2012 Aug;17(6):940-9. doi: 10.1111/j.1440-1843.2012.02190.x.
Patients with chronic obstructive pulmonary disease (COPD) may experience depression and sleep disorders, which can adversely affect their health-related quality of life (HRQOL). The aim of this study was to investigate depression and sleep disorders among 85 COPD patients and 46 control subjects, aged 40 years and over.
Patients underwent spirometry and arterial blood gas analysis, self-completed St. George's respiratory questionnaire and were assessed on the center for epidemiologic studies depression (CES-D) and the Pittsburgh sleep quality index (PSQI). The frequency of exacerbations among COPD patients was prospectively monitored for 12 months.
The prevalence of depression and sleep disorders was significantly higher among COPD patients than control subjects. The relative risks (95% confidence interval) of depression and sleep disorders were 7.58 (1.03 to 55.8) and 1.82 (1.03 to 3.22), respectively, in COPD patients compared with control subjects. Among COPD patients, there was a correlation between CES-D and PSQI. Lower body mass index, more severe dyspnoea, poorer HRQOL, lower partial pressure of arterial oxygen and higher partial pressure of arterial carbon dioxide were significantly associated with the incidence of depression and sleep disorders. Exacerbations and hospitalizations were more frequent among COPD patients with depression than those with sleep disorders alone or those without depression or sleep disorders.
Depression and sleep disorders are very common co-morbidities among COPD patients and significantly reduce activities and HRQOL among these patients. Depression, but not sleep disorder, is an independent risk factor for exacerbations and hospitalization among COPD patients.
慢性阻塞性肺疾病(COPD)患者可能会经历抑郁和睡眠障碍,这会对其健康相关生活质量(HRQOL)产生不利影响。本研究旨在调查 85 例 COPD 患者和 46 例年龄在 40 岁及以上的对照组患者的抑郁和睡眠障碍情况。
患者接受了肺功能检查和动脉血气分析,自行完成圣乔治呼吸问卷,并接受了流行病学研究中心抑郁量表(CES-D)和匹兹堡睡眠质量指数(PSQI)评估。前瞻性监测 COPD 患者的 12 个月内的病情加重频率。
COPD 患者的抑郁和睡眠障碍发生率明显高于对照组。与对照组相比,COPD 患者的抑郁和睡眠障碍的相对风险(95%置信区间)分别为 7.58(1.03 至 55.8)和 1.82(1.03 至 3.22)。在 COPD 患者中,CES-D 与 PSQI 之间存在相关性。较低的体重指数、更严重的呼吸困难、更差的 HRQOL、较低的动脉血氧分压和较高的动脉二氧化碳分压与抑郁和睡眠障碍的发生显著相关。与单纯睡眠障碍或无抑郁或睡眠障碍的 COPD 患者相比,有抑郁的 COPD 患者的病情加重和住院更为频繁。
抑郁和睡眠障碍是 COPD 患者常见的共病,显著降低了这些患者的活动能力和 HRQOL。抑郁而不是睡眠障碍是 COPD 患者病情加重和住院的独立危险因素。